References in periodicals archive ?
In the Carvedilol or Metoprolol European Trial (COMET) 3,029 patients with heart failure were randomized to receive either carvedilol or immediate-release metolprolol tartrate.
The Carvedilol or Metoprolol European Trial (COMET) enrolled 3,029 patients with moderate to severe heart failure from 341 centers in 15 European countries.
In the Carvedilol or Metoprolol European Trial (COMET), (1) patients with heart failure were randomized to receive either carvedilol or metoprolol in addition to their current diuretic and angiotensin-converting enzyme inhibitor.